Patent details

Basic Information

Publication number:

EP3209778

PCT Application Number:

EP2015074271

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157846288

PCT Publication Number:

WO2016062722

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION

French Title of Invention:

ASSOCIATION MÉDICAMENTEUSE

German Title of Invention:

KOMBINATION

SPC Number:

Dates

Filing date:

20/10/2015

Grant date:

03/04/2019

EP Publication Date:

30/08/2017

PCT Publication Date:

28/04/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/04/2019

EP B1 Publication Date:

03/04/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/10/2019

Expiration date:

20/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/03/2019

 

 

Name:

Astrazeneca AB

Address:

., 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:

WOESSNER, Richard

Address:

United States (US)

2

Name:

LYNE, Paul Dermot

Address:

United States (US)

3

Name:

MCCOON, Patricia Elizabeth

Address:

United States (US)

Priority

Priority Number:

201462068141 P

Priority Date:

24/10/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/7088; C12N 15/11;

Publication

European Patent Bulletin

1

Issue number:

201914

Publication date:

03/04/2019

Description:

Grant (B1)

2

Issue number:

201918

Publication date:

01/05/2019

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages